Migraine Prevention: Evidence-Based Treatments and Lifestyle Strategies
The goal of preventive therapy is to reduce attack frequency, severity, duration, and disability; improve acute treatment response; prevent medication-overuse headache; and enhance quality of life. Indicated when: ≥4 migraine days/month, disabling attacks, contraindication/failure to acute meds, or patient preference.
Oral Preventive Medications (First-Line per AHS/AAN Guidelines)
| Class | Examples | Key Points |
|---|---|---|
| Beta-blockers | Propranolol, metoprolol, timolol | Level A evidence; avoid in asthma, bradycardia, depression. |
| Anticonvulsants | Topiramate, valproate (avoid in pregnancy), zonisamide | Topiramate: weight loss, cognitive side effects (word-finding). |
| Antidepressants | Amitriptyline, nortriptyline, venlafaxine | TCAs: sedating, anticholinergic; SNRIs for comorbid depression/anxiety. |
| Calcium channel blockers | Verapamil | Less evidence; useful if other classes contraindicated. |
| CGRP mAbs (oral) | Atogepant, rimegepant | Newer; also approved for acute treatment; no titration needed. |
Injectable/Infusion Preventives
- CGRP Monoclonal Antibodies (monthly/quarterly SC/IV): Erenumab, fremanezumab, galcanezumab, eptinezumab. High efficacy, excellent tolerability, no daily pill burden.
- OnabotulinumtoxinA (Botox): FDA-approved for chronic migraine (≥15 headache days/mo). 31-site injection protocol q12 weeks. Effective for chronic migraine with medication overuse.
Neuromodulation Devices
- External (non-invasive): Cefaly (supraorbital V1 stimulation), gammaCore (nVNS), Nerivio (remote electrical neuromodulation), Relivion (combined occipital/trigeminal).
- Implanted (invasive): Occipital nerve stimulator, sphenopalatine ganglion stimulator—reserved for refractory cases.
Lifestyle Modifications (SEEDS Mnemonic)
- Sleep: Consistent schedule, 7–9 hrs, treat apnea.
- Exercise: 150 min/week moderate aerobic (reduces frequency ~30%).
- Eat: Regular meals, hydration, avoid triggers (aged cheese, alcohol, aspartame, MSG, nitrates).
- Diary: Track triggers, patterns, treatment response.
- Stress management: CBT, mindfulness, biofeedback, relaxation training.
Special Populations
- Pregnancy: Avoid valproate, topiramate, CGRP mAbs (limited data). Prefer propranolol, amitriptyline, magnesium, behavioral therapy.
- Children/Adolescents: Topiramate, propranolol, amitriptyline; CBT + lifestyle first-line.
- Older adults: Start low, go slow; watch drug interactions, falls, cognitive effects.
Monitoring & Expectations
- Therapeutic trial: 2–3 months at target dose.
- 50% responder rate (≥50% reduction in migraine days) is typical benchmark.
- Combination therapy (medication + behavioral) often superior to either alone.
- Reassess every 6–12 months; taper if sustained remission.
Migraine - Related Articles
- Food & Migraines: Understanding Dietary Triggers & Symptoms
- Demerol for Migraines: Uses, Risks, and Alternatives
- Migraine Pathophysiology: The Role of Blood Vessel Dilation and Neurovascular Mechanisms
- Migraine Information: Consult a Healthcare Professional for Guidance
- In-Hospital Migraine Treatment: When and What to Expect
- Migraine Relief: How Diet Impacts Headaches
- Combining Maxalt and Midrin for Migraines: Why Medical Consultation Is Essential
